Why Switzerland Why Switzerland Swiss Biotech Center: innovative solutions for biopharmaceutical development
Life sciences Geneva start-up STALICLA signs exclusive in-licensing agreement with Novartis 16 January 2023
Life sciences Life sciences Biopôle expands further with the construction of three new buildings 3 October 2022
Life sciences Clexbio and CSEM join forces to develop the first device to produce vein implants 5 July 2022